Avammune Therapeutics

📍 Philadelphia, United States🗓 Founded 2019👥 16 employees💰 Last funded Mar 2025
Biotechnology Research🌐 avammune.com
Website LinkedIn
Avammune Therapeutics is a drug discovery company focused on the development of novel immunotherapeutics to address high unmet medical needs. Our research is driven by the science that have a potential to create a significant difference on the disease platform. Our expertise lies on developing small molecule drugs that can be administered systemically and can potentially overcome the issues faced by the currently available therapeutics for cancer and immunological disorders. We work with experts in disease biology to achieve this goal which aims at improving the lives of patients significantly. Our research efforts has led to successful completion of projects in the immunoncology space.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
India
2
Frequently asked questions
Who invested in Avammune Therapeutics?
Avammune Therapeutics has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Avammune Therapeutics last raise funding?
The most recent investment in Avammune Therapeutics recorded on gritt.io was in March 2025.
When was Avammune Therapeutics founded?
Avammune Therapeutics was founded in 2019.
What industry is Avammune Therapeutics in?
Avammune Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Avammune Therapeutics based?
Avammune Therapeutics is headquartered in Philadelphia, United States.